Insights On Partnering
-
Breaking Free From Process Paralysis In Clinical Trials
1/13/2025
Explore the implementation of CRIO’s eSource solution by a leading pharmaceutical company to overcome process paralysis in clinical research.
-
Muscular Dystrophy: Multi-National And Multi-Site Trials
10/15/2024
Learn about the success ReveraGen found when expanding their partnership with Novotech to a larger phase 2b trial (VBP15-004) in Duchenne Muscular Dystrophy (DMD).
-
How Do Site Payments Impact Clinical Trial Sustainability?
4/16/2025
Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,
-
Built For Sites To Benefit All
7/15/2024
This one-minute video highlights the benefits of One Home for Sites. Join the movement to increase clinical trial capacity, because patients are waiting.
-
EACT: Eliminating The Financial Burden For Patients
6/7/2024
Explore the EACT project's resources at eactproject.org to help reduce financial barriers and enhance participation in clinical trials.
-
Uncovering The Root Cause Of Clinical Trial Troubles
12/10/2024
Discover essential strategies to prevent clinical trials from reaching a crisis while gaining a deeper understanding of the importance of addressing systemic issues early.
-
The Evolving RNA Landscape: Navigating Science, Strategy, And Global Markets
10/27/2025
Learn how to streamline development, reduce costs, and accelerate the path to market for next-generation RNA therapies.
-
Ease Is How Good Work Happens
11/17/2025
Clinical research teams thrive in the Flow State, where systems align, data connects, and work becomes purposeful, not painful. Ease is clarity, not complexity.
-
Backup Sites: The Closers Of Clinical Trials
4/22/2024
Backup or coverage sites are usually brought in at the same time as others but are not activated. These sites become add-on or rescue sites, or the clinical equivalent of baseball’s ninth inning.
-
Ergomed's Solutions To The Challenges of Oncology Trials
4/15/2025
Explore a pivotal Phase III global clinical trial investigating neoadjuvant immunotherapy for locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).